Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Filings indexed 386 across all filing types
Latest filing 2022-09-07 Capital/Financing Update
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the completion of a sale-and-leaseback transaction involving Cresco Labs' property. It details the transaction terms, parties involved, and strategic implications for the company. There is no indication of financial statements, regulatory filings, or detailed financial performance data. The document is relatively short (3643 characters) and serves as a capital/financing update rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-09-07 English
News release - English.pdf
Regulatory Filings
2022-08-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-19 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-19 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-08-19 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Cresco Labs' financial results for the second quarter ended June 30, 2022. It includes comprehensive financial highlights such as revenue, adjusted EBITDA, gross profit, balance sheet data, and management commentary. It also discusses ongoing M&A activity, specifically the acquisition of Columbia Care, and provides forward-looking statements. The document mentions that the financial information is based on unaudited management-prepared financial statements and that the company expects to file its unaudited interim condensed consolidated financial statements on SEDAR shortly. The presence of detailed financial data for a quarter, management discussion, and financial metrics indicates this is a quarterly financial report rather than a brief earnings release or a simple announcement. The document length (15,000 characters) and content depth confirm it is a substantive financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q2 2022
2022-08-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.